BBTX Stock Forecast: Bambusa Therapeutics, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$16

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 0 of 100 as at 21 Nov 2026 — in the weakest quartile.

Market cap
$815.1M
Ticker Nerd rank
0/ 100
Median analyst target
—
Analysts covering
—
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Bambusa Therapeutics, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
0/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
20
Growth
10
Value
10
Momentum
9
Quality
5
Accruals
5
Volatility
4
Issuance
0

Revisions (20): Analysts have, on balance, been raising their forecasts.

Issuance (0): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

BBTX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BBTX, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

BBTX appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Estimates

BBTX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
—
Price / book
—
EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
—
Returns & dividend
Return on equity
—
Return on assets
—
Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Bambusa Therapeutics, Inc. has a market value of $815.1M and an enterprise value of $192.9M.

  • Shares outstanding: 50.9M.

  • Bambusa Therapeutics, Inc. employs 26 people.

market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

BBTX and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
BBTXBambusa Therapeutics, Inc.$815.1M0
ODTXOdyssey Therapeutics, Inc.$800.1M1
CRVSCorvus Pharmaceuticals, Inc.$810.0M48
MGTXMeiraGTx Holdings Plc$779.9M70
MTRIMentari Therapeutics, Inc.$776.4M24
LTGOLatigo Biotherapeutics, Inc.$822.1M1
VSTMVerastem, Inc.$769.1M39

Take a look at BBTX’s peer groups, ranked by the model: healthcare stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Bambusa Therapeutics, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about BBTX

How does Ticker Nerd's model rank BBTX?

As at 21 Nov 2026, Bambusa Therapeutics, Inc. ranks 0 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (20 of 100).

What is the BBTX stock forecast for 2030?

No analyst covering Bambusa Therapeutics, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BBTX are extrapolating price history, which says nothing about the business.

What does Bambusa Therapeutics, Inc. do?

Bambusa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing long-acting precision bispecific antibodies for immunology and inflammatory diseases. Its research platform combines established biologic pathways with multi-target antibody engineering and high-concentration subcutaneous formulations designed to support durable treatment and convenient administration.

Company

About Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing long-acting precision bispecific antibodies for immunology and inflammatory diseases. Its research platform combines established biologic pathways with multi-target antibody engineering and high-concentration subcutaneous formulations designed to support durable treatment and convenient administration. The company’s pipeline includes BBT001, which targets IL-4Rα and IL-31 for atopic dermatitis and other inflammatory skin conditions; BBT002, which targets IL-4Rα and IL-5 for Type 2 inflammatory disorders; and preclinical programs addressing inflammatory bowel disease and autoantibody-driven autoimmune diseases. Bambusa Therapeutics, Inc. operates within the biotechnology and healthcare markets, serving the development needs of patients with chronic immune-mediated conditions and the broader biopharmaceutical ecosystem. Headquartered in Boston, Massachusetts, the company represents a specialized participant in the clinical development of next-generation antibody therapies.

CEO Dr. Shanshan Xu M.B.A., M.D., Ph.D. · 26 employees · United States · https://www.bambusatx.com